12:00 AM
Oct 25, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Lambda: Began Phase III testing

Shire Pharmaceuticals Group plc (LSE:SHP; SHPGY), Andover, U.K.
Product: Lambda
Business: Renal
Therapeutic category: Metabolism
Target: Dietary phosphate...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >